Atomoxetine (Strattera) Dosing for an 8-Year-Old
For an 8-year-old child with ADHD, start atomoxetine at approximately 0.5 mg/kg/day for the first 3-7 days, then increase to a target dose of 1.2 mg/kg/day, with a maximum of 1.4 mg/kg/day or 100 mg/day (whichever is lower). 1
Initial Dosing Strategy
The weight-based approach is critical for this age group:
- Starting dose: Begin at approximately 0.5 mg/kg/day (total daily dose)
- Target dose: Titrate to 1.2 mg/kg/day after 3-7 days
- Maximum dose: 1.4 mg/kg/day or 100 mg/day, whichever is lower 1
Dosing Schedule Options
You have two evidence-based approaches for administration:
Option 1 (Preferred for tolerability): Divide the total daily dose into twice-daily dosing (morning and late afternoon/early evening), with gradual titration over 1-2 weeks. This approach reduces early adverse events, particularly decreased appetite (8.0% vs 14.3%) and somnolence (4.2% vs 14.3%) compared to rapid titration 2.
Option 2: Once-daily morning dosing is also effective and may improve adherence, though it carries slightly higher risk of early side effects if titrated rapidly 3.
Titration Timeline
- Days 1-7: Start at 0.5 mg/kg/day (divided into two doses if using twice-daily regimen)
- Week 2 onward: Increase to target dose of 1.2 mg/kg/day
- If needed: Can increase to maximum 1.4 mg/kg/day after several weeks if response is inadequate 1
Critical Safety Monitoring
Before initiating treatment, you must:
- Obtain personal and family cardiac history (sudden death, cardiovascular symptoms, Wolff-Parkinson-White syndrome, hypertrophic cardiomyopathy, long QT syndrome) 4
- If any cardiac risk factors are present, obtain ECG and consider cardiology referral 4
- Monitor closely for suicidal ideation, clinical worsening, and unusual behavioral changes, especially during the first few months and at dose changes (FDA black box warning) 1
Ongoing monitoring should include:
- Heart rate and blood pressure (atomoxetine can increase both) 4
- Growth parameters (height and weight) - atomoxetine may cause initial growth delays in first 1-2 years 4
- Hepatic function if symptoms of hepatitis develop (extremely rare but reported) 4
Common Adverse Effects to Anticipate
The most frequent side effects in children are 1:
- Nausea and vomiting
- Decreased appetite
- Abdominal pain
- Fatigue and somnolence
These are typically transient and can be minimized by slow titration with twice-daily dosing 2.
Important Drug Interactions
- CYP2D6 inhibitors (certain SSRIs like fluoxetine, paroxetine) can significantly elevate atomoxetine levels - approximately 7% of the population are poor CYP2D6 metabolizers with naturally higher plasma levels and increased risk of adverse effects 1
- If the child is on a CYP2D6 inhibitor or is a known poor metabolizer, start at lower doses and titrate more cautiously
Clinical Context
Atomoxetine is FDA-approved for children aged 6 years and older 1. For this 8-year-old, the medication is well within the approved age range. The evidence shows that 1.2 mg/kg/day is as effective as 1.8 mg/kg/day in most children without comorbid oppositional defiant disorder, making it the appropriate initial target 5. The 0.5 mg/kg/day dose shows intermediate efficacy and is best used only as a starting dose 5.
Avoid abrupt discontinuation - while atomoxetine does not require tapering like alpha-2 agonists, gradual discontinuation is prudent to monitor for symptom return 4.